Pharmaceutical

Bavarian Nordic expands access to mpox vaccine in US

Jynneos contributed $725m in sales to Bavarian Nordic in 2023, being a huge driver in revenues for the company.

Apr 3, 2024 - 00:00
Bavarian Nordic expands access to mpox vaccine in US
Jynneos contributed $725m in sales to Bavarian Nordic in 2023, being a huge driver in revenues for the company.
Read the original article

Tags:

Previous Article

These plants evolved in Florida millions of years ago. They may be gone in decades.

Next Article

Partnerships are key to driving digital healthcare transformation in US, say exp...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Inari Medical to buy last-line amputation prevention company LimFlow

STAT+: Inari Medical to buy last-line amputation preven...

Nov 3, 2023

STAT+: Eli Lilly’s Mounjaro succeeds in second weight loss study, paving way for FDA review

STAT+: Eli Lilly’s Mounjaro succeeds in second weight l...

Apr 27, 2023

US PTO voids Seagen’s ADC patent infringement claims against Daiichi

US PTO voids Seagen’s ADC patent infringement claims ag...

Jan 17, 2024